As of 2025-07-11, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (13.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 131.87 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -110.4%.
The range of the Relative Valuation is (13.10) - (13.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 18.6x | 18.6x |
| Forward P/E multiples | 18.7x - 20.8x | 20.6x |
| Fair Price | (13.10) - (13.04) | (13.74) |
| Upside | -109.9% - -109.9% | -110.4% |
| Date | P/E |